Stay updated on Pembrolizumab & Endocrine Therapy Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & Endocrine Therapy Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.0%
    Check dated 2025-05-01T06:06:05.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The webpage has been updated to include new information about the clinical trial for metastatic breast carcinoma, specifically mentioning the drug Palbociclib and the involvement of the National Cancer Institute. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.
    Difference
    59%
    Check dated 2025-04-16T17:23:11.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to January 29, 2025.
    Difference
    0.2%
    Check dated 2025-04-09T12:55:09.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new last update date of March 25, 2025, and a revision change to version 2.14.3, replacing the previous date of January 29, 2025, and version 2.14.2.
    Difference
    0.2%
    Check dated 2025-04-01T23:55:42.000Z thumbnail image
  8. Check
    85 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    0.8%
    Check dated 2025-02-24T22:49:43.000Z thumbnail image
  9. Check
    99 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    0.8%
    Check dated 2025-02-10T16:00:35.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & Endocrine Therapy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & Endocrine Therapy Clinical Trial page.